Johns Hopkins University
Dr. Judith Karp is professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. A board-certified oncologist, Dr. Karp is an authority on the molecular mechanisms of leukemias and lymphomas, with a primary clinical interest in the experimental therapeutics of acute leukemias. She also directs the leukemia program within the division of hematologic malignancies and is co-principal investigator (with Dr. Michael Carducci and Michelle Rudek) of the NCI Cooperative Agreement (U01) grant for early drug development. She is responsible for the clinical direction of the Heme 2 inpatient leukemia service and the portfolio of early phase clinical trials of new agents with unique mechanisms of action for adult acute leukemias and high-risk myelodysplasia (MDS).
Dr. Karp received her MD from Stanford University School of Medicine and completed her residency and fellowship at John Hopkins.
She chaired the 2010 Oncology Care Live online oncology congress, presented by Johns Hopkins University School of Medicine.
You need to be logged in to save this episode to a playlist.